Antilip Advance is a food supplement for the Cardiovascular System health. Find out details about its properties, patenting and production.

Antilip Advance is a patented food supplement based on a harmonized combination of polyglucosamine, phytosterols from Brassica rapa campestris, Monacolin K from Monascus purpureus, chromium picolinate, Vitamin C and Vitamin B6.

Antilip Advance is available in tablets; it is recommended to take two tablets half an hour before dinner. For people that do not need to keep under control the glucose level Antilip is recommended. 


Claim and Safety

It contributes to the maintenance of normal blood cholesterol levels (monacolin K), to the maintenance of normal blood glucose level (chromium picolinate), to normal protein and glycogen metabolism (Vit. B6), to the protection of the cells from oxidative stress (Vit. C) and to the normal collagen formation for the normal function of blood vessels (Vit. C).*


*EFSA Claim as defined by the EU Regulation 1924/2006

The product is safe and conforms to Directive 2002/46/EC.

The recommended daily dose should not be exceeded. Food supplements are not a substitute for a balanced and varied diet and a healthy lifestyle. Keep away from children below 3 years old.
Consult your doctor before using this product. Do not use it in pregnancy, during lactation and in case of therapy with hypolipidemic drugs.

Scientific Background

Plasma Cholesterol levels are defined by the amount produced by the body and the amount assumed through the diet. Cholesterol is absorbed in the intestine, transported to the liver and then released into the bloodstream. When cholesterol levels are significantly higher than physiological levels, conditions such as hypercholesterolaemia may occur, leading to negative effects on the well-being of the body.

Glucose is a simple monosaccharide, which represents the most important source of energy for the human body, it is absorbed into the bloodstream through the intestinal walls and part of it is stored in liver and muscle tissues in polymeric form, as glycogen. The latter acts as an energetic reservoir that is consumed in case of need to satisfy the demand for glucose. An altered glucose metabolism can lead to an excessive accumulation of glucose, leading  to a state known as  hyperglycaemia.

Hypercholesterolemia and hyperglycemia represent risk factors for the development of coronary artery disease and other metabolic disorders.

Patent

Antilip Advance is covered by patents in Italy (1373986), in the EU (EP1996207), in the USA (US9050356), in Japan (JP5557451) and in Mexico (MX2008011289).

Cardiovascular supplements